BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30183076)

  • 1. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
    Lee KH; Hong S; Kang M; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Cancer; 2018 Dec; 143(11):2849-2861. PubMed ID: 30183076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.
    Tang DE; Dai Y; He JX; Lin LW; Leng QX; Geng XY; Fu DX; Jiang HW; Xu SH
    J Pathol; 2020 Oct; 252(2):101-113. PubMed ID: 32617978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
    Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
    Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
    Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
    Liu JS; Fang WK; Yang SM; Wu MC; Chen TJ; Chen CM; Lin TY; Liu KL; Wu CM; Chen YC; Chuu CP; Wang LY; Hsieh HP; Kung HJ; Wang WC
    J Biomed Sci; 2022 May; 29(1):29. PubMed ID: 35534851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens.
    Yeh IJ; Song K; Wittmann BM; Bai X; Danielpour D; Montano MM
    Biochem J; 2014 Sep; 462(2):315-27. PubMed ID: 24844355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
    Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
    Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.
    Duan L; Chen YA; Liang Y; Chen Z; Lu J; Fang Y; Cao J; Lu J; Zhao H; Pong RC; Hernandez E; Kapur P; Tran TAT; Smith T; Martinez ED; Ahn JM; Hsieh JT; Luo JH; Liu ZP
    Biomed Pharmacother; 2023 Feb; 158():114077. PubMed ID: 36495660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
    Higashijima Y; Matsui Y; Shimamura T; Nakaki R; Nagai N; Tsutsumi S; Abe Y; Link VM; Osaka M; Yoshida M; Watanabe R; Tanaka T; Taguchi A; Miura M; Ruan X; Li G; Inoue T; Nangaku M; Kimura H; Furukawa T; Aburatani H; Wada Y; Ruan Y; Glass CK; Kanki Y
    EMBO J; 2020 Apr; 39(7):e103949. PubMed ID: 32125007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer.
    Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC
    Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964
    [No Abstract]   [Full Text] [Related]  

  • 15. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
    Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
    Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3.
    Maina PK; Shao P; Jia X; Liu Q; Umesalma S; Marin M; Long D; Concepción-Román S; Qi HH
    Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):1002-1012. PubMed ID: 28734980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity.
    Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kwak C; Kim HH
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.